Yourchoicetx

3 known investors

YourChoice Therapeutics is developing YCT-529, a non-hormonal oral contraceptive for men currently in Phase 2 clinical trials. The company targets male contraceptive users seeking alternatives to condoms or vasectomy.

BiotechFemTechHealthtech